Literature DB >> 2410693

Inhibitory effect of calcium antagonists on the depletion of cardiac norepinephrine during postischemic reperfusion.

W G Nayler, W J Sturrock.   

Abstract

We have investigated whether Ca2+ antagonists of the dihydropyridine type (nifedipine, nisoldipine, and nitrendipine) attenuate or abolish the ischemia-reperfusion-induced depletion of the cardiac stores of norepinephrine (NE). The experiments were performed using isolated, Langendorff-perfused rat hearts. Ischemia (global) was induced for 15 or 60 min at 37 degrees C and was followed by normothermic reperfusion. Left ventricular NE content was assayed by high-performance liquid chromatography with electrochemical detection. The continued presence of nifedipine (0.03 microM), nisoldipine (0.03 microM), or nitrendipine (0.03 microM) before and after the ischemic episode abolished the loss of NE caused by 15 min but not 60 min of ischemia and reperfusion. Nifedipine, 0.03 microM, but not diltiazem, 0.24-1.22 microM, or verapamil, 0.22-1.09 microM, attenuated (p less than 0.05) NE depletion when added only on reperfusion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410693     DOI: 10.1097/00005344-198505000-00026

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Nifedipine and experimental cardioprotection.

Authors:  W G Nayler; J J Liu; S Panagiotopoulos
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

3.  Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection.

Authors:  R Ferrari; A Cargnoni; P Bernocchi; G Gaia; M Benigno; E Pasini; P Pedersini; C Ceconi
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 4.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

5.  Regulation of the L-type calcium channel alpha-1 subunit by chronic depolarization in the neuron-like PC12 and aortic smooth muscle A7r5 cell lines.

Authors:  O Feron; T Godfraind
Journal:  Pflugers Arch       Date:  1995-07       Impact factor: 3.657

6.  Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration.

Authors:  R Ferrari; G M Boffa; C Ceconi; S Curello; A Boraso; S Ghielmi; A Cargnoni
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

Review 7.  Protective effects of calcium antagonists against ischaemia and reperfusion damage.

Authors:  R Ferrari; O Visioli
Journal:  Drugs       Date:  1991       Impact factor: 9.546

8.  Effect of lacidipine on ischaemic and reperfused isolated rabbit hearts.

Authors:  A Boraso; A Cargnoni; L Comini; G Gaia; P Bernocchi; R Ferrari
Journal:  Mol Cell Biochem       Date:  1993-08-11       Impact factor: 3.396

9.  In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain.

Authors:  E Pileblad; A Carlsson
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.